glioblastoma

You have access
Transcription factor-based gene therapy to treat glioblastoma through direct neuronal conversion
Xin Wang, Zifei Pei, Aasma Hossain, Yuting Bai and Gong Chen

Cancer Biology & Medicine August 2021, 18 (3) 860-874; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0499
You have access
Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev

Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
You have access
Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
Ruichao Chai, Guanzhang Li, Yuqing Liu, Kenan Zhang, Zheng Zhao, Fan Wu, Yuzhou Chang, Bo Pang, Jingjun Li, Yangfang Li, Tao Jiang and Yongzhi Wang

Cancer Biology & Medicine February 2021, 18 (1) 271-282; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0179
You have access
BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas
Shangfeng Gao, Zhuang Sha, Junbo Zhou, Yihao Wu, Yunnong Song, Cheng Li, Xuejiao Liu, Tong Zhang and Rutong Yu

Cancer Biology & Medicine February 2021, 18 (1) 88-104; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0096
You have access
Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma
Shaoping Shen, Ling Chen, Jialin Liu, Lin Yang, Mengna Zhang, Lingxiong Wang, Rong Zhang, Yasushi Uemura, Qiyan Wu, Xinguang Yu and Tianyi Liu

Cancer Biology & Medicine August 2020, 17 (3) 555-568; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0027
You have access
TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma
Yingbin Xie, Luyue Chen, Junhu Zhou, Chao Yang, Can Xu, Xiangyu Fan, Yanli Tan, Yanan Wang, Chunsheng Kang and Chuan Fang

Cancer Biology & Medicine August 2020, 17 (3) 664-675; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0356
You have access
Downregulation of SNRPG induces cell cycle arrest and sensitizes human glioblastoma cells to temozolomide by targeting Myc through a p53-dependent signaling pathway
Yulong Lan, Jiacheng Lou, Jiliang Hu, Zhikuan Yu, Wen Lyu and Bo Zhang

Cancer Biology & Medicine February 2020, 17 (1) 112-131; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0164
You have access
TNFa inhibitor C87 sensitizes EGFRvIII transfected glioblastoma cells to gefitinib by a concurrent blockade of TNFa signaling
Li Ma, Chunhua She, Qian Shi, Qiang Yin, Xinxin Ji, Yongrong Wang, Yulong Fan, Xinyao Kong, Peng Li, Zengfeng Sun, Xiaohui Zhang, Zhen Zhang, Jian Wang, Tong Wang, Yuanfu Xu and Wenliang Li

Cancer Biology & Medicine August 2019, 16 (3) 606-617; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0011
You have access
Autophagic flux response and glioblastoma sensitivity to radiation
Achilleas G. Mitrakas, Dimitra Kalamida, Alexandra Giatromanolaki, Stamatia Pouliliou, Avgi Tsolou, Rafail Kyranas and Michael I. Koukourakis

Cancer Biology & Medicine August 2018, 15 (3) 260-276; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0173
You have access
Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistance
Si-Han Wu, Jun-Feng Bi, Timothy Cloughesy, Webster K. Cavenee and Paul S. Mischel

Cancer Biology & Medicine December 2014, 11 (4) 255-263; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.04.004

Main menu

User menu

Search

glioblastoma

Pages

Navigate

More Information

For Authors

Journal Services